You're using an outdated browser. This website will not display correctly and some features will not work.
Learn more about the browsers we support for a faster and safer online experience.

 

ONTARIO regulation 374/02

made under the

drug interchangeability and dispensing fee act

Made: December 11, 2002
Filed: December 16, 2002
Printed in The Ontario Gazette: January 4, 2003

Amending Reg. 935 of R.R.O. 1990

(General)

Note: Since the end of 2001, Regulation 935 has been amended by Ontario Regulations 63/02 and 215/02.  Previous amendments are listed in the Table of Regulations published in The Ontario Gazette dated January 19, 2002.

1. Section 1 of Regulation 935 of the Revised Regulations of Ontario, 1990 is amended by adding the following subsections:

(3) For the purposes of this Regulation, items 301 and 309 of Part III of the Formulary shall be deemed to have been revoked and item 309 shall be deemed to read as follows:

SALBUTAMOL  4.6400

309

100mcg/Met Dose Inh-200 dose Pk

 

 

 

 

00790419

Apo-Salvent (Not a Benefit)

APX

 

 

00851841

Salbutamol Inhaler (Not a benefit)

KNR

 

 

00874086

Novo-Salmol (Not a benefit)

NOP

 

 

02213478

Ventolin (Not a benefit)

GLW

 

 

02232570

Airomir HFA

MMH

4.6500

 

02244914

Ratio-Salbutamol HFA

RAI

4.6400

 

02245669

+Apo-Salvent CFC Free

APX

4.6400

(4) For the purposes of this Regulation, the reference in Part III of the Formulary to 022441914 Alti-Salbutamol HFA 100mcg/MET Dose Inh-200 Dose Pk SALBUTAMOL SULFATE ALT 4.64 shall be read as if it did not exist.

2. This Regulation comes into force on January 1, 2003.